Concepedia

David Y. Oh

DY

Statistics

Publications

30

Citations

3.6K

H-Index

23

Active since

2000

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Harvard University

University of California System

University of California, Los Angeles

David Y. Oh is an author at University of California, San Francisco specializing in life sciences, oncology, and immunology.

ORCID

Publications per year

2000–2025

30

Publications

30

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

David Y. Oh, Serena S. Kwek, Siddharth S. Raju et al. · Cell · 2020 · 747 citations · Full text

, , +17

Tumor Suppressor NM23-H1 Is a Granzyme A-Activated DNase during CTL-Mediated Apoptosis, and the Nucleosome Assembly Protein SET Is Its Inhibitor

Zusen Fan, Paul J. Beresford, David Y. Oh et al. · Cell · 2003 · 529 citations · Full text

, , +15

Non-viral precision T cell receptor replacement for personalized cell therapy

Susan P. Foy, Kyle Jacoby, Daniela A. Bota et al. · Nature · 2022 · 278 citations · Full text

, , +17

Androgen conspires with the CD8 <sup>+</sup> T cell exhaustion program and contributes to sex bias in cancer

Hyunwoo Kwon, Johanna M. Schafer, No‐Joon Song et al. · Science Immunology · 2022 · 243 citations · Full text

, , +17

Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire

David Y. Oh, Jason Cham, Li Zhang et al. · Cancer Research · 2016 · 242 citations

, , +17

1–5 of 30